CEBPA and breast carcinoma: Furthermore, the breast cancer patients’ survival probability in high methylated CEBPA group was dramatically lower than that in low methylated CEBPA group (Fig. 4H), based on the best critical prognostic index analysis of a database from SurvivalMeth (Fig. S3C).